IP Library Granted Patent US 9,593,096
Granted Patent B2
US 9,593,096 · App. 14/786,798 · Granted Mar 14, 2017

α7 nicotinic acetylcholine receptor modulators and uses thereof-III

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,593,096
App. No.
14/786,798
Granted
Mar 14, 2017
Kind
B2
Abstract

The present invention relates to chemical compounds useful in the positive modulation of the alpha 7 nicotinic acetylcholine receptor (α7 nAChR).

Claims (9)

1. A compound of Formula (Ib), or a pharmaceutically acceptable salt thereof:

wherein

R 1 is selected from pyridine or pyrimidine, each of which is substituted with one of F or CF 3 ;

R 2 is selected from hydrogen or C 1 -C 4 alkyl;

R 3 is C 1 -C 4 alkyl; and

R 4 ′ is selected from F, halo C 1 -C 4 alkyl or halo C 1 -C 6 alkoxy.

2. A compound of claim 1 , wherein R 2 is hydrogen or methyl.

3. A compound or a pharmaceutically acceptable salt thereof, which is:

4. A composition comprising a compound of claim 1 , or a pharmaceutically acceptable salt thereof and at least one pharmaceutically acceptable adjuvant, carrier or diluent.

Assignments (1)
MERGER Recorded Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →